Cancer is a complex disease characterized by a wide array of mutually interacting components constituting the tumor microenvironment (connective tissue, vascular system, immune cells), many of which are targeted therapeutically. In particular, immune checkpoint inhibitors have recently become an established part of the treatment of cancer. Despite great promise, only a portion of the patients display durable response. Current research efforts are concentrated on the determination of tumor-specific biomarkers predictive of response, such as tumor mutational burden, microsatellite instability, and neo-antigen presentation. However, it is clear that several additional characteristics pertaining to the tumor microenvironment play a critical rol...
International audienceTumors are highly heterogeneous tissues where malignant cells are surrounded b...
The tumor microenvironment (TME) is a multifaceted ecosystem characterized by profound cellular hete...
Cancer constantly evolves to evade the host immune system and resist different treatments. As a cons...
A large number of tumor intrinsic and extrinsic factors determine long-term survival in human cancer...
The immune response to a given cancer can profoundly influence a tumour’s trajectory and response t...
The immunologic landscape of tumors has been continuously unveiled, providing a new look at the inte...
The developments of sequencing technologies in the past two decades have enabled exciting findings a...
Introduction: Haematological malignancies originate and progress in primary and secondary lymphoid o...
Next generation sequencing has allowed researchers to characterise the somatic landscape of cancer g...
During cancer development, malignant tumours accumulate genetic and epigenetic alterations that caus...
Among classical exemplifications of tumor microenvironment (TME) in lymphoma pathogenesis, the “effa...
In the microenvironment of a malignancy, tumor cells do not exist in isolation, but rather in a dive...
The accurate quantification of tumor-infiltrating immune cells turns crucial to uncover their role i...
This PhD thesis studies dimensionality reduction using independent component analysis as a methodolo...
peer reviewedBackground: The amount of publicly available cancer-related“omics”data is constantly gr...
International audienceTumors are highly heterogeneous tissues where malignant cells are surrounded b...
The tumor microenvironment (TME) is a multifaceted ecosystem characterized by profound cellular hete...
Cancer constantly evolves to evade the host immune system and resist different treatments. As a cons...
A large number of tumor intrinsic and extrinsic factors determine long-term survival in human cancer...
The immune response to a given cancer can profoundly influence a tumour’s trajectory and response t...
The immunologic landscape of tumors has been continuously unveiled, providing a new look at the inte...
The developments of sequencing technologies in the past two decades have enabled exciting findings a...
Introduction: Haematological malignancies originate and progress in primary and secondary lymphoid o...
Next generation sequencing has allowed researchers to characterise the somatic landscape of cancer g...
During cancer development, malignant tumours accumulate genetic and epigenetic alterations that caus...
Among classical exemplifications of tumor microenvironment (TME) in lymphoma pathogenesis, the “effa...
In the microenvironment of a malignancy, tumor cells do not exist in isolation, but rather in a dive...
The accurate quantification of tumor-infiltrating immune cells turns crucial to uncover their role i...
This PhD thesis studies dimensionality reduction using independent component analysis as a methodolo...
peer reviewedBackground: The amount of publicly available cancer-related“omics”data is constantly gr...
International audienceTumors are highly heterogeneous tissues where malignant cells are surrounded b...
The tumor microenvironment (TME) is a multifaceted ecosystem characterized by profound cellular hete...
Cancer constantly evolves to evade the host immune system and resist different treatments. As a cons...